Martin McLaughlin

3.0k citations
38 papers · 2.1k · 1 hit paper · h-index 25

Impact in

  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
  • Catalysis top 5%
    • Ionic liquids properties and applications

Papers in

    • DNA Repair Mechanisms 7
    • Cell death mechanisms and regulation 4
    • CAR-T cell therapy research 7
    • Cancer-related Molecular Pathways 5
    • Cancer Immunotherapy and Biomarkers 4

Martin McLaughlin

36 papers receiving 2.1k citations

Martin McLaughlin's Hit Papers

Inflammatory microenvironment remodelling by tumour cells after radiotherapy 2020 · 601 citations
6010+2+4Years since publication200400600

Peers

Martin McLaughlin
Comparison fields: 5 of 122
  • Oncology 834
  • Catalysis 167
  • Immunology 474
  • Microbiology 105
  • Geriatrics and Gerontology 53
Replace Lihua Qiu with:
Lihua Qiu China
Luyao Zhang China
Yugang Liu China
Xiaoping Wang China
Vivien C. Yee United States
Weiying Zhou China
Bastiaan Nuijen Netherlands
Yujie Shi China
Dante Neculai China
Xudong Wang China
Martin McLaughlin relative to Lihua Qiu China Lihua Qiu's profile →
Citations per field
00.5×6.6×
Lihua Qiu · 1×
Citations per year

Countries citing papers authored by Martin McLaughlin

Since Specialization
Citations

This map shows the geographic impact of Martin McLaughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin McLaughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin McLaughlin more than expected).

Fields of papers citing papers by Martin McLaughlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin McLaughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin McLaughlin. The network helps show where Martin McLaughlin may publish in the future.

Co-authors

The 25 scholars most cited alongside Martin McLaughlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Martin McLaughlin Line = papers co-authored together Martin McLaughlin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Inflammatory microenvironment remodelling by tumour cells after radiotherapy
Hit paper breakdown →
2020601
2 2019146
3 2010136
4 2001118
5 2010109
6 201682
7 201062
8 201453
9 202049
10 201248
11 201646
12 201246
13 201244
14 201841
15 201141
16 201640
17 201340
18 201538
19 201333
20 201231

About Martin McLaughlin

Martin McLaughlin is a scholar working on Molecular Biology, Oncology, Genetics, Immunology and Biotechnology, having authored 38 papers that have together received 2.1k indexed citations. Recurring topics across this work include Virus-based gene therapy research (12 papers), CAR-T cell therapy research (7 papers), DNA Repair Mechanisms (7 papers), Cancer Research and Treatments (5 papers), Cancer-related Molecular Pathways (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), interferon and immune responses (4 papers) and Cell death mechanisms and regulation (4 papers). The work is most often cited by research in Oncology (834 citations), Catalysis (167 citations), Immunology (474 citations), Microbiology (105 citations) and Geriatrics and Gerontology (53 citations). Martin McLaughlin has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Kevin J. Harrington, Malin Pedersen, Magnus T. Dillon, Alan Melcher, Emmanuel C. Patin, Anna Wilkins, Brendan Gilmore, Sean P. Gorman, Garry Laverty and Joan Kyula. Their work appears in journals such as Molecular Cancer Therapeutics, Radiotherapy and Oncology, Clinical Cancer Research, Green Chemistry and Gene Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact